Pancreatic cancer with synchronous liver and colon metastases: A case report

Table 1 Literature review of the characteristics of pancreatic cancer patients with colon metastasis

Ref.	Age, yr	Sex	Metastatic site	Timing of metastasis	Immunohistochemical staining	Treatment	OS from CM Dx
Charles et al[21]	45	Male	Colon	NA	CA19-9 (+), CK (+), EMA (+), CEA (+), CDX2 (-), CK20 (-), CK7 (-), CD10 (-), vimentin (-), TTF-1) (-)	NA	NA
Kentaro et al[4]	62	Male	Colon	Metachronous	CK7 (+), CK20 (-)	Hemicolectomy	NA
Woogyeong et al[3]	64	Male	Colon	Metachronous	CK7 (+), CK20 (-), CK19 (+)	Hemicolectomy + gemcitabine	6+
Giuseppe et al[5]	70	Female	Liver, colon	Synchronous	CK7 (+), CK20 (-)	NA	NA
Ryan et al[6]	91	Female	Colon	Synchronous	CK7 (+), CK20 (-), CDX2 (-)	Palliative care	NA
Deborah et al[7]	73	Female	Colon	Synchronous	CK7 (+), CK20 (-), CDX2 (-), SATB2 (-)	Gemcitabine + nab-paclitaxel	7 mo
Rohan et al[8]	71	Male	Colon	Synchronous	CK7 (+), CK20 (-)	Gemcitabine + nab-paclitaxel	NA

CM: Colon metastasis; NA: Not available; EMA: Epithelial membrane antigen; CEA: Carcinoembryonic antigen; TTF-1: Thyroid transcription factor-1; CK: Cytokeratin; OS: Overall survival.